Lung Cancer Surgery Market to Approach $6.73 Billion by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Lung Cancer Surgery Market From 2026 To 2030?
The lung cancer surgery market has shown substantial growth recently. It is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to several factors, including rising lung cancer incidence rates, improved hospital surgical capabilities, the availability of proficient thoracic surgeons, the increasing adoption of video-assisted thoracoscopic surgery, and enhanced awareness regarding early-stage lung cancer treatment.
The lung cancer surgery market is expected to experience consistent growth over the next few years. It is projected to expand to $6.73 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.7%. This anticipated growth can be attributed to several factors during the forecast period, such as the increasing integration of robotic surgery platforms, a rising demand for precise surgical outcomes, the expansion of specialized cancer care centers, growing investments in surgical technology, and the wider adoption of enhanced recovery after surgery protocols. Major trends identified for this period include the increasing uptake of minimally invasive surgical techniques, a surge in the use of robotic-assisted thoracic surgery, a growing preference for lung-preserving procedures, the broader utilization of advanced surgical instruments, and an enhanced focus on post-surgical recovery outcomes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp
Which Important Drivers Are Guiding The Lung Cancer Surgery Market Growth?
The rising prevalence of lung cancer is anticipated to drive the expansion of the lung cancer surgery market moving forward. Lung cancer is characterized by the uncontrolled proliferation of abnormal cells within one or both lungs, which can disrupt their normal functioning. This increasing incidence of lung cancer is attributed to prolonged exposure to air pollution, particularly fine particulate matter, as these minute particles can penetrate deeply into lung tissue, leading to inflammation, cellular damage, and genetic mutations that contribute to cancer development. Lung cancer surgery plays a crucial role in reducing deaths related to the disease by enabling the early excision of malignant tumors before they can metastasize or advance. For example, according to the Centers for Disease Control and Prevention, a US-based federal government agency, it was reported in June 2025 that lung cancer was responsible for 131,584 deaths in the United States in 2023, following 218,893 newly reported cases in 2022. Therefore, the escalating occurrence of lung cancer is a primary driver propelling growth in the lung cancer surgery market.
Which Segments Define The Lung Cancer Surgery Market Segment Structure?
The lung cancer surgery market covered in this report is segmented –
1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users
Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
What Trends Are Influencing The Evolution Of The Lung Cancer Surgery Market?
Leading companies operating in the lung cancer surgery market are prioritizing the development of innovative technologies, such as robotic-assisted surgeries, to improve surgical precision, shorten recovery times, and enhance patient outcomes. Robotic-assisted surgeries denote minimally invasive procedures performed with robotic systems controlled by surgeons, intended to boost accuracy, lessen complications, and better patient recovery. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers enhanced reach and stability for accessing small, challenging-to-reach lung nodules, consequently improving the capacity for earlier lung cancer diagnosis. Its advanced maneuverability and integration with imaging technologies facilitate more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports greater clinical confidence and consistency across a wider range of bronchoscopic procedures.
Who Are The Established Players Within The Lung Cancer Surgery Market?
Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH
Get The Full Lung Cancer Surgery Market Report:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report
Where Is The Lung Cancer Surgery Market Primarily Concentrated By Region?
North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Lung Cancer Surgery Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report
Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company
Lung Cancer Diagnostic And Screening Market Report 2026
Non Small Cell Lung Cancer Nsclc Market Report
Non Small Cell Lung Cancer Nsclc Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
